| 期 |
栏目 |
标题 |
文件 |
| 卷 510, 编号 1 (2023) |
Articles |
MODULAR NANOTRANSPORTERS CAPABLE OF BINDING WITH SARS-COV-2 VIRUS NUCLEOCAPSID PROTEIN INTO TARGET CELLS |
|
| 卷 509, 编号 1 (2023) |
Articles |
INTRACELLULAR DELIVERY OF ANTIBODY-LIKE MOLECULE, CAPABLE TO INHIBIT C-MYC |
|
| 卷 509, 编号 1 (2023) |
Articles |
SELECTION OF AN AMINO ACID SITE WITH ONE OF THE FASTEST CLEAVAGE KINETICS BY THE ENDOSOMAL PROTEASE CATHEPSIN B FOR POTENTIAL USE IN DRUG DELIVERY SYSTEMS |
|
| 卷 515, 编号 1 (2024) |
Articles |
Quantitative description of the N-protein of the SARS-CoV-2 virus degradation in cells stably expressing it under the influence of new modular nanotransporters |
|
| 卷 515, 编号 1 (2024) |
Articles |
Modular nanotransporters capable of cause intracellular degradation of the N-protein of the SARS-CoV-2 virus in A549 cells with temporary expression of this protein fused with the fluorescent protein mRuby3 |
|
| 卷 520, 编号 1 (2025) |
Articles |
GALA3-containing modular nanotransporters are capable of delivering Keap1 monobody to target cells and inhibiting the formation of reactive oxygen species in the cells |
|
| 卷 521, 编号 1 (2025) |
Articles |
Optimization of A549 cell transfection efficiency with a plasmid encoding the N-protein of the SARS-COV-2 virus |
|
| 卷 521, 编号 1 (2025) |
Articles |
Increasing the accumulation of modular nanotransporters in mouse tumors by attaching polyethylene glycol to these nanotransporters with the possibility of its release into the tumors |
|
| 卷 521, 编号 1 (2025) |
Articles |
Modular nanotransporters containing Keap1 monobodies are capable of reducing the toxic effect of acetaminophen on the liver of mice |
|
